12:00 AM
 | 
May 17, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Herceptin trastuzumab: Marketed

Researchers presented long-term (median 25-month follow-up) data showing a significant improvement in overall survival for 235 patients receiving Herceptin in combination with...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >